Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion
Key facts
- Who runs it
- University of British Columbia
- Where
- Canada7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 220 people, planned
- Started
- 1 Jun 2022
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Graded Exposure Therapy
- Prescribed aerobic exercise
- Enhanced usual care
- Record updated
- 31 March 2026
Who can take part
- Age
- 18 years to 69 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- aged 18-70 years
- sustained a concussion according to the ACRM mTBI Task Force definition between 1 and 24 months ago
- fluent in English, because validated translations are not available for most questionnaires and recruiting multilingual therapists is not feasible
- access to a computer, tablet, or smartphone with internet capability
- 3 or more moderate-severe symptoms on the Rivermead Postconcussion Symptom Questionnaire
Who cannot take part
- medical contraindication to aerobic exercise (cardiac disease, chest pain with exertion, acute bone/joint/soft tissue injury aggravated by exercise)
- severe/unstable medical or psychiatric condition that could worsen over the next year")
- change in cardiac medication within the last month, such as beta blockers, calcium channel blockers, or ivabradine
- involved in personal injury litigation for index mTBI
- currently pregnant or plan to become pregnant within the next three months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Concussions are very common. Although many people recover well from concussion, some will have persistent symptoms and difficulties with daily activities. How people cope with their symptoms following concussion powerfully influences their recovery. Fear avoidance behaviour is a particularly unhelpful approach to coping, in which people perceive their pre-injury activities as unnecessarily dangerous and take great care to avoid overexertion and overstimulation. The investigators developed and pilot tested a behavioural therapy, called graded exposure therapy, to reduce fear avoidance behaviour. Our preliminary work suggested that graded exposure therapy was acceptable to patients with concussion and possibly beneficial for their recovery. The GET FAB after concussion study will assess the effectiveness of graded exposure therapy.
The 3 groups in the trial
- Arm 1: Graded Exposure TherapyTreatment being tested
Treatment: Graded Exposure Therapy
- Arm 2: Prescribed Aerobic ExerciseExisting treatment, for comparison
Treatment: Prescribed aerobic exercise
- Arm 3: Enhanced usual careExisting treatment, for comparison
Treatment: Enhanced usual care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Graded Exposure Therapy for Fear Avoidance Behaviour (GET FAB) After Concussion
- Publications
- Record updated
- 31 March 2026